Beyond Air

Beyond Air Corporate Partner AARC Gold Corporate Partner

Beyond Air is harnessing nitric oxide’s pulmonary, antimicrobial, and immunomodulatory mechanisms of action to empower healthcare providers and deliver global access to more treatment options from hospital to home. Our late-stage active pipeline of LungFit® products generate and deliver low and high concentration iNO from room air, using ionization technology.

Our FDA-approved LungFit PH® system delivers unlimited, on-demand generation of nitric oxide from room air, regardless of dose or flow. No cylinders, no hassle.

  • The first and only 3-in-1 integrated system for inhaled nitric oxide (iNO) generation, delivery, and monitoring1
  • Fast, precise, simple: Power on, generate, and deliver iNO within 1 minute2
  • An all-inclusive partnership with LungFlex™, our 24/7 customer service and support
Indications for Use

The nitric oxide from the LungFit PH System is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. Refer to the full Prescribing Information within the LungFit PH System Operator’s Manual before use. Please visit for full Important Safety Information.

  1. LungFit PH System Operator’s Manual. Garden City, NY: Beyond Air Inc. 2022.
  2. Data on file. Beyond Air Inc. 2021.

Heading to the New Era

Elevate | Engage | Advocate | Educate